RT Book, Section A1 Ikediobi, Ogechi A1 Nangia, Julie A1 Trivedi, Meghana V. A2 Bertino, Joseph S. A2 DeVane, C. Lindsay A2 Fuhr, Uwe A2 Kashuba, Angela D. A2 Ma, Joseph D. SR Print(0) ID 56877193 T1 Chapter 13. Pharmacogenomics in Oncology T2 Pharmacogenomics: An Introduction and Clinical Perspective YR 2013 FD 2013 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-174169-9 LK accesspharmacy.mhmedical.com/content.aspx?aid=56877193 RD 2024/03/29 AB Define and explain carcinogenesis and cancer genetics.Identify the most common germline variants and describe how these can modulate treatment outcome.Describe how somatic variants can predict drug response.Discuss pharmacogenomics in oncology clinical trials.